In October 2019, MEPC confirmed that the 138,000 sqft speculative development scheme at its high-tech business estate, Silverstone Park, will be increased to 258,000 sqft due to market demand. The construction of the development is underway and MEPC have released stunning imagery and aerial footage that...
James Cowper Kreston (JCK) is ranked one of the largest accounting and business advisory networks in the world. They work alongside the Thames Valley Chamber of Commerce (TVCC) to deliver inward investment into the Thames Valley and have interests in India and South East Asia. This...
Oxfordshire Local Enterprise Partnership (OxLEP) has produced a presentation that explores the many ways in which Oxfordshire’s life sciences sector is responding to the pandemic. The response from the county’s life sciences sector to COVID-19 has been immediate – a mass-mobilisation which is witnessing ground-breaking research...
Oxfordshire, one of the leading life sciences and healthcare clusters in Europe, is home to numerous national assets and leading companies from within the sector. Learn more about one of Europe’s most- successful Life Sciences clusters with a track record in establishing and attracting world-leading life...
Buckinghamshire Local Enterprise Partnership (Bucks LEP) has launched its new website, which aims to provide latest information on key developments across Buckinghamshire’s Enterprise Zones. Since 2016 the Aylesbury Vale Enterprise Zone has provided an enormous boost to help Buckinghamshire grow its existing businesses and attract and...
Secretary of State Liz Truss launches tech industry support measures to help UK tech companies easily expand into overseas markets. New measures to boost digital trade and help turn the UK into a global tech powerhouse have been announced by the International Trade Secretary, answering industry...
The South East retains its place in the top three UK regions for total FDI projects according to the EY Attractiveness survey. The annual EY report examines the performance and perceptions of the UK and its regions as destinations for FDI, and this year includes...
Oxford Biomedica, a leading gene and cell therapy group, has signed a one-year clinical and commercial supply deal with AstraZeneca for a potential Covid-19 vaccine. The agreement relates to the adenovirus vector-based vaccine candidate AZD1222, which entered clinical trials at multiple sites in the UK recently. Oxford...
A revolutionary new medical device, that can predict coronary artery disease, which is the number one cause of death in the UK and globally, has been developed by Ultromics, a health-tech spin-out from the University of Oxford. The pioneering technology, called EchoGo Pro, is the first...
Construction of the UK’s new Vaccines Centre has begun ahead of schedule. The highly specialist facility will house the Vaccines Manufacturing and Innovation Centre (VMIC) that will provide the UK’s first bespoke strategic vaccine development and manufacturing capability. The rapidly accelerated programme will aim to see...